Showing results (81-90 of 580) with videos related to
Sort By:
Pageof 58
Cell Cycle (Georgetown, Tex.)|March 30, 2010
Biologic and experimental variation of measured cancer stem cellsMichael Heuser, R Keith HumphriesBlood|April 28, 2010
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemiaFelicitas Thol, Frederik Damm, Katharina Wagner, et al.Blood|May 15, 2007
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AMLMichael Heuser, Bob Argiropoulos, Florian Kuchenbauer, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2007
Therapeutic use of erythropoietin in dermatooncologyImke Satzger, Florian Schenck, Felicitas Thol, et al.Oligonucleotides|April 28, 2007
Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture modelAnuhar Chaturvedi, Karin Battmer, Daniel Schaefer, et al.Blood|October 24, 2002
Specific inhibition of bcr-abl gene expression by small interfering RNAMichaela Scherr, Karin Battmer, Thomas Winkler, et al.Blood|April 26, 2024
Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantationClara Philine Wienecke, Bennet Heida, Letizia Venturini, et al.Deutsches Arzteblatt International|March 16, 2012
Cutaneous side effects of new antitumor drugs: clinical features and managementRalf Gutzmer, Andreas Wollenberg, Selma Ugurel, et al.Leukemia Research|May 4, 2004
Cross-trial networking in AML: a step forward rather than corner cuttingThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.Experimental Hematology|June 21, 2005
Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemiaWenji Piao, Jens Grosse, Andreas Czwalinna, et al.Pageof 58